NO20075920L - Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria - Google Patents

Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria

Info

Publication number
NO20075920L
NO20075920L NO20075920A NO20075920A NO20075920L NO 20075920 L NO20075920 L NO 20075920L NO 20075920 A NO20075920 A NO 20075920A NO 20075920 A NO20075920 A NO 20075920A NO 20075920 L NO20075920 L NO 20075920L
Authority
NO
Norway
Prior art keywords
ferroquine
malaria
treatment
artemisinin derivative
association
Prior art date
Application number
NO20075920A
Other languages
English (en)
Inventor
Laurent Fraisse
Daniel Ter-Minassian
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20075920L publication Critical patent/NO20075920L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Oppfinnelsen vedrører en kombinasjon omfattende ferroquin, som fri base, salt, hydrat eller solvat form, og et artemisininderivat. Oppfirmelsen vedrører også en farmasøytisk sammensetning omfattende ferroquin i form av dets farmasøytisk akseptable salter, ferroquinhydrat eller solvat og minst ett artemisininderivat. Oppfinnelsen vedrører videre anvendelsen av en slik kombinasjon for fi-emstilling av et preparat for behandling eller forhindring av malaria. Til slutt vedrører oppfirmelsen et kit for behandling eller forhindring av malaria.
NO20075920A 2005-04-20 2007-11-16 Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria NO20075920L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0503932A FR2884715B1 (fr) 2005-04-20 2005-04-20 Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme
PCT/FR2006/000842 WO2006111647A1 (fr) 2005-04-20 2006-04-18 Association entre la ferroquine et un derive d’artemisinine pour le traitement du paludisme

Publications (1)

Publication Number Publication Date
NO20075920L true NO20075920L (no) 2007-11-16

Family

ID=35385843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075920A NO20075920L (no) 2005-04-20 2007-11-16 Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria

Country Status (30)

Country Link
US (1) US20120258945A1 (no)
EP (1) EP1874293A1 (no)
JP (1) JP5148478B2 (no)
KR (1) KR20080009088A (no)
CN (2) CN101163470A (no)
AP (1) AP2782A (no)
AR (1) AR054253A1 (no)
AU (1) AU2006238506B2 (no)
BR (1) BRPI0610851A2 (no)
CA (1) CA2605385A1 (no)
CR (1) CR9425A (no)
DO (1) DOP2006000092A (no)
EA (1) EA012630B1 (no)
FR (1) FR2884715B1 (no)
GT (1) GT200600157A (no)
HN (1) HN2006015130A (no)
IL (1) IL186048A0 (no)
MA (1) MA29451B1 (no)
MX (1) MX2007012645A (no)
MY (1) MY145581A (no)
NO (1) NO20075920L (no)
NZ (1) NZ562117A (no)
PA (1) PA8669801A1 (no)
PE (2) PE20110119A1 (no)
SG (1) SG161270A1 (no)
TN (1) TNSN07359A1 (no)
TW (1) TWI387456B (no)
UA (1) UA96414C2 (no)
WO (1) WO2006111647A1 (no)
ZA (1) ZA200708800B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926993B1 (fr) * 2008-02-06 2011-03-11 Sanofi Aventis Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme
FR2952823B1 (fr) * 2009-10-30 2012-04-20 Sanofi Aventis Utilisation de la ferroquine dans le traitement ou la prevention du paludisme
FR2951945B1 (fr) * 2009-11-05 2013-08-09 Sanofi Aventis Composition pharmaceutique
FR2961209B1 (fr) * 2010-06-11 2013-03-01 Sanofi Aventis Procede de synthese de la ferroquine par amination reductrice convergente.
FR2989588A1 (fr) * 2012-04-19 2013-10-25 Centre Nat Rech Scient Composes pour la prevention ou le traitement des infections par des virus de la famille des flaviviridae
BR112016009827B1 (pt) 2013-11-08 2021-10-26 Exthera Medical Corporation Método in vitro para concentrar patógenos infecciosos presentes em uma amostra biológica obtida a partir de um indivíduo sob suspeita de estar infectado com os ditos patógenos, concentrador e kit
CN105250295B (zh) * 2014-07-07 2018-12-25 广州中医药大学科技产业园有限公司 一种联合用药物及其作为免疫调节剂的应用
US10512652B2 (en) 2015-07-20 2019-12-24 University Of Vermont And State Agricultural College Use of cymanquine compounds as antimalarial agents
CN107802755A (zh) * 2017-11-08 2018-03-16 江西龙卿堂科技有限公司 一种具有防蚊防疟作用的青蒿软膏
KR102073961B1 (ko) * 2018-11-16 2020-02-05 (주)프론트바이오 메트포르민 및 페로센계 화합물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물
US20240207251A1 (en) * 2021-04-26 2024-06-27 Min Bo SHIM Pharmaceutical composition containing artesunate or salt thereof and pyronaridine or salt thereof, for antipyresis, anti-inflammatory efficacy, anti-viral efficacy and treatment or prevention of covid-19, and method using same
CN113952360B (zh) * 2021-09-14 2023-03-10 上海交通大学 一种亚铁离子在治疗疟疾的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166154B (no) * 1987-05-08 1990-03-24 Hoechst India
WO2005023304A2 (en) * 2003-09-04 2005-03-17 Cipla Limited Antimalarial compositions and manufacturing process thereof

Also Published As

Publication number Publication date
SG161270A1 (en) 2010-05-27
WO2006111647A1 (fr) 2006-10-26
AP2782A (en) 2013-10-31
CN102836163A (zh) 2012-12-26
IL186048A0 (en) 2008-02-09
MA29451B1 (fr) 2008-05-02
BRPI0610851A2 (pt) 2010-08-03
PE20110119A1 (es) 2011-03-08
MX2007012645A (es) 2007-12-13
CA2605385A1 (fr) 2006-10-26
CN101163470A (zh) 2008-04-16
JP2008536900A (ja) 2008-09-11
ZA200708800B (en) 2009-01-28
AR054253A1 (es) 2007-06-13
EA012630B1 (ru) 2009-10-30
NZ562117A (en) 2010-01-29
HN2006015130A (es) 2010-08-19
TWI387456B (zh) 2013-03-01
FR2884715B1 (fr) 2007-06-15
GT200600157A (es) 2006-11-07
EP1874293A1 (fr) 2008-01-09
FR2884715A1 (fr) 2006-10-27
MY145581A (en) 2012-02-29
AU2006238506A1 (en) 2006-10-26
UA96414C2 (ru) 2011-11-10
KR20080009088A (ko) 2008-01-24
TW200716092A (en) 2007-05-01
AU2006238506B2 (en) 2012-03-01
PE20061314A1 (es) 2006-12-27
DOP2006000092A (es) 2006-11-15
AP2007004211A0 (en) 2007-10-31
CR9425A (es) 2008-02-20
PA8669801A1 (es) 2006-11-09
JP5148478B2 (ja) 2013-02-20
US20120258945A1 (en) 2012-10-11
TNSN07359A1 (en) 2008-12-31
EA200702282A1 (ru) 2008-02-28

Similar Documents

Publication Publication Date Title
NO20075920L (no) Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria
NO20090593L (no) Modulatorer av farmakokinetikkegenskaper til terapeutika
IL238479A0 (en) c2 th5 receptor modulator preparations and methods of use
NO20091395L (no) Nye tiofenderivater
NO20082793L (no) Nye tiofenderivater
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20082088L (no) Azetidiner som MEK-inhibitorer for behandling av proliferative sykdommer
DK1797088T3 (da) Hidtil ukendte chromen-2-on-derivater og anvendelse heraf som monoamin-neurotransmitter-genoptagelseshæmmere
NO20085257L (no) Purinonderivater som HM74a-agonister
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
IL195732A (en) Pharmaceutical compounds containing passoterodine, their use and method for their preparation
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
DK1675591T3 (da) Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer
NO20054876D0 (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
MX2010003923A (es) Formulacion farmaceutica de valsartan.
DK1768748T4 (da) Sammensætninger omfattende strontium og vitamin D og anvendelser deraf
MX2010003495A (es) Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas.
UY29169A1 (es) Derivados de 2-amido-4 feniltiazol, su preparacion y su aplicacion en terapeutica
WO2007056142A3 (en) Methods of preventing the serotonin syndrome and compositions for use therefor
NO20071299L (no) Vedvarende frigivelse farmasoytisk sammensetning av tolterodine
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
UY29859A1 (es) Derivados de 1-amino-isiquinolina,su preparación y su aplicación terapéutica
CL2008003231A1 (es) Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura.
WO2008039894A3 (en) Atorvastatin pharmaceutical compositions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application